Science Saturday: Antimalarials, COVID-19, cardiac arrest
Over the last few weeks, chloroquine and hydroxychloroquine have become household words. These antiparasitic drugs normally prescribed for malaria were introduced early in the rush to find potential treatments for COVID-19. As time goes on, the public discussion has centered on who should get these particular drugs and when. Meanwhile many doctors and medical researchers [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - April 24, 2020 Category: Research Source Type: news
How Mayo Clinic is using artificial intelligence in its COVID-19 research
Artificial intelligence has a vital role in helping researchers in their efforts to fight COVID-19 and is an important tool in the work being done at Mayo Clinic. Dr. Andrew Badley is an infectious diseases specialist and leads Mayo Clinic's COVID-19 Research Task Force. In this Q&A, Dr. Badley answers questions about the task force [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - April 23, 2020 Category: Research Source Type: news
Science Saturday: The importance of antibody testing in addressing COVID-19
If there's one thing the world has learned so far in the course of the COVID-19 pandemic, it's the important role of testing for the disease. The ability to know who has the virus and who doesn't provides critical information for people and entire regions. Early testing involved collecting cells from the back of the [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - April 3, 2020 Category: Research Source Type: news
Guidance on patients at risk of drug-induced sudden cardiac death from off-label COVID-19 treatments
ROCHESTER, Minn. ? SARS-CoV-2, the virus that causes COVID-19, continues to spread, leading to more than 20,000 deaths worldwide in less than four months. Efforts are progressing to develop a COVID-19 vaccine, but it's still likely 12 to 18 months away. In the meantime, the pandemic, with over 400,000 confirmed cases worldwide already, is driving [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - March 24, 2020 Category: Research Source Type: news
Mayo Clinic's patient-centered values and culture drive its 2030 strategy to cure, connect and transform health care
ROCHESTER, Minn. -- Mayo Clinic is well-positioned, with remarkable progress in 2019, to reinforce its leadership in patient care, research and education, and drive forward the transformation of health care over the next decade. Mayo Clinic's path to 2030 is rooted in its patient-centered values and humanitarian mission, to cure, connect and transform health care [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - February 24, 2020 Category: Research Source Type: news
Florida State University and Mayo Clinic collaborate on medical innovation, attracting top biomedical talent in Florida
JACKSONVILLE, Fla. ?John Thrasher, president of Florida State University (FSU), and Mayo Clinic representatives signed a multifaceted agreement on Tuesday, Feb. 25, in Jacksonville to attract and retain top talent in the biomedical field. The collaborative education efforts will focus on medical innovation and promote a market-driven approach to create a highly trained workforce focused [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - February 24, 2020 Category: Research Source Type: news
New Hope for Regaining His Old Life After Being Paralyzed
Paralyzed from the neck down as a result of a surfing accident, Chris Barr thought life as he knew it was over. After enrolling in a regenerative medicine clinical trial at Mayo Clinic, however, he began to realize all was not lost. Chris Barr wanted to give up and give in. A surfing accident in [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - January 12, 2020 Category: Research Source Type: news
Study finds less-aggressive chemotherapy after initial treatment for metastatic colorectal cancer to be more beneficial
PHOENIX -- A Mayo Clinic study involving 5,540 patients with metastatic colorectal cancer finds that maintenance chemotherapy after initial treatment is more beneficial for patients whose disease is under control, compared with more aggressive treatment. A maintenance strategy with a fluoropyrimidine chemotherapy, such as 5-FU or capecitabine, is preferred, though observation with no chemotherapy is [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - December 18, 2019 Category: Research Source Type: news
Many younger patients with stomach cancer have a distinct disease, Mayo research discovers
ROCHESTER, Minn. -- Many people under 60 who develop stomach cancer have a "genetically and clinically distinct" disease, new Mayo Clinic research has discovered. Compared to stomach cancer in older adults, this new, early onset form often grows and spreads more quickly, has a worse prognosis, and is more resistant to traditional chemotherapy treatments, the [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - December 16, 2019 Category: Research Source Type: news
Study reveals major health issues U.S. breast cancer survivors face following diagnosis
Researchers found most women who survive breast cancer beyond 10 years are at risk to develop serious medical conditions including heart disease, cerebrovascular disease and Alzheimer's disease Overall survival of patients with breast cancer in the U.S. has significantly improved over the past two decades. However, as breast cancer survivors live longer, their risk of [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - December 15, 2019 Category: Research Source Type: news
Science Saturday: Good Advice on Obesity? Wait for it...
With obesity, good advice only goes so far. What's good for one person hasn't turned out to be good for all, and it's left patients and physicians adrift. Michael Jensen, M.D., a Mayo Clinic endocrinologist, began studying obesity 34 years ago when it seemed manageable. "There was sort of a false sense of optimism," says Dr. Jensen. [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - December 6, 2019 Category: Research Source Type: news
Science Saturday: Platelet rich plasma found to be effective in regrowing hair
Platelets spun from a person's own blood may be a new option for treating baldness in women, according to research at Mayo Clinic's Florida campus. A pilot study found platelet rich plasma (PRP), a regenerative therapy associated with natural growth factors and tissue healing, regrows hair as well as other treatments on the market. The findings could lead [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - November 15, 2019 Category: Research Source Type: news
Experimental cholesterol-lowering drug effective at lowering bad cholesterol, study shows
PHILADELPHIA -- Twice-yearly injections of an experimental cholesterol-lowering drug, inclisiran, were effective at reducing low-density lipoprotein (LDL) cholesterol, often called bad cholesterol, in patients already taking the maximum dose of statin drugs, according to data of the ORION-10 trial presented Saturday, Nov. 16, at the American Heart Association's Scientific Sessions 2019. High levels of LDL [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - November 15, 2019 Category: Research Source Type: news
Science Saturday: Mimicking cancer, one model at a time
One April, Mayo Clinic oncologist Gerardo Colon-Otero, M.D., found himself the bearer of good and bad news. The good news was that he had discovered the cause of his patient's severe stomach aches. The bad news was that the culprit was a tumor the size of a tennis ball, lodged in the patient's pancreas. To make matters [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - November 1, 2019 Category: Research Source Type: news
Common early sign of cardiovascular disease also may indicate cancer risk, study finds
ROCHESTER, Minn. -- A Mayo Clinic-led study involving 488 cardiac patients whose cases were followed for up to 12 years finds that microvascular endothelial dysfunction, a common early sign of cardiovascular disease, is associated with a greater than twofold risk of cancer. The study, published in the European Journal of Preventive Cardiology, finds that microvascular [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - October 30, 2019 Category: Research Source Type: news
